PFG Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $281K | Sell |
1,741
-953
| -35% | -$154K | 0.01% | 529 |
|
|
2025
Q1 | $458K | Sell |
2,694
-885
| -25% | -$151K | 0.03% | 496 |
|
|
2024
Q4 | $595K | Buy |
3,579
+2,301
| +180% | +$382K | 0.04% | 425 |
|
|
2024
Q3 | $220K | Sell |
1,278
-73
| -5% | -$12.6K | 0.01% | 666 |
|
|
2024
Q2 | $208K | Buy |
+1,351
| New | +$208K | 0.01% | 645 |
|
|
2023
Q3 | – | Sell |
-2,948
| Closed | -$451K | – | 629 |
|
|
2023
Q2 | $451K | Sell |
2,948
-264
| -8% | -$40.4K | 0.03% | 414 |
|
|
2023
Q1 | $498K | Sell |
3,212
-108
| -3% | -$16.7K | 0.04% | 382 |
|
|
2022
Q4 | $512K | Buy |
3,320
+214
| +7% | +$33K | 0.05% | 356 |
|
|
2022
Q3 | $410K | Buy |
+3,106
| New | +$410K | 0.05% | 356 |
|
|
2022
Q2 | – | Sell |
-4,421
| Closed | -$659K | – | 405 |
|
|
2022
Q1 | $659K | Sell |
4,421
-1,991
| -31% | -$297K | 0.07% | 240 |
|
|
2021
Q4 | $1.04M | Sell |
6,412
-451
| -7% | -$73K | 0.1% | 243 |
|
|
2021
Q3 | $1.14M | Sell |
6,863
-1,894
| -22% | -$315K | 0.13% | 217 |
|
|
2021
Q2 | $1.51M | Sell |
8,757
-2,008
| -19% | -$347K | 0.17% | 164 |
|
|
2021
Q1 | $1.73M | Sell |
10,765
-4,717
| -30% | -$757K | 0.22% | 137 |
|
|
2020
Q4 | $2.6M | Sell |
15,482
-3,225
| -17% | -$542K | 0.44% | 60 |
|
|
2020
Q3 | $3.04M | Buy |
18,707
+3,149
| +20% | +$512K | 0.58% | 41 |
|
|
2020
Q2 | $2.7M | Buy |
15,558
+2,247
| +17% | +$389K | 0.61% | 40 |
|
|
2020
Q1 | $2.07M | Buy |
+13,311
| New | +$2.07M | 0.56% | 47 |
|
|
2019
Q4 | – | Sell |
-9,532
| Closed | -$1.16M | – | 301 |
|
|
2019
Q3 | $1.16M | Sell |
9,532
-377
| -4% | -$45.7K | 0.32% | 100 |
|
|
2019
Q2 | $1.35M | Buy |
9,909
+1,435
| +17% | +$195K | 0.37% | 89 |
|
|
2019
Q1 | $1.17M | Buy |
8,474
+698
| +9% | +$96.7K | 0.36% | 91 |
|
|
2018
Q4 | $1.11M | Buy |
+7,776
| New | +$1.11M | 0.35% | 94 |
|